|
CN102429876A
|
|
Liraglutide sustained-release microsphere preparation and preparation method thereof
|
|
CN102423484A
|
|
Stable cetrorelix medicinal composition and preparation method thereof
|
|
CN102329373A
|
|
Solid-phase synthetic process for degarelix
|
|
CN102417474A
|
|
New method for preparing D-iso-glutamoyl-D-tryptophan
|
|
CN102321170A
|
|
Liraglutide variant and conjugate thereof
|
|
CN102286092B
|
|
Solid-phase synthesis method of liraglutide
|
|
CN102319418A
|
|
Buserelin preparation and preparation method thereof
|
|
CN102198103A
|
|
Stable exenatide sustained-release microsphere preparation and preparation method thereof
|
|
CN102210872A
|
|
Polyethylene glycol modified peptide pharmaceutical formulation and preparation method thereof
|
|
CN102106828A
|
|
Thymalfasin sustained-release microsphere preparation and preparation method thereof
|
|
CN101602802A
|
|
Process for desalting Thymosin alpha1
|
|
CN101555272A
|
|
Solid phase preparation method of carbetocin
|
|
CN101531705A
|
|
Method for purifying Carbetocin
|
|
CN101538324A
|
|
Method for preparing Exenatide
|
|
CN101597325A
|
|
Method for purifying Leuprorelin
|
|
CN101538323A
|
|
Method for purifying Exenatide
|
